STL Volume 19 Number 3

STL Volume 19 Number 3
Purchase PDF for $2.79
Update on Drugs and Drug News

Update on Drugs and Drug News: May-June 2014

Update on Brimonidine tartrate 0.33% topical gel (Onreltea®Mirvaso®), Apremilast tablets (Otezla®), Miltefosine capsules (Impavido®), Hydrogel wound dressing (Loutrex®), Omalizumab for SC injection (Xolair®), Propranolol hydrochloride oral solution (Hemangeol™), Microbicide-coated condom Vivagel® (SPL7013 gel)

Recent Approval of Xerese in Canada: 5% Acyclovir and 1% Hydrocortisone Topical Cream in...

Herpes labialis is a frequently occurring viral infection of the lips and oral mucosa. Clinical data on the efficacy of topical combination acyclovir-hydrocortisone (Xerese™) product in treating herpes labialis are discussed.

Rosacea: An Update on Medical Therapies

Rosacea is a common, chronic cutaneous condition that affects the face. Various conventional and emerging therapies for rosacea are reviewed.